Some therapies have been shown to work in clinical studies and other research Authors: Jared S. Hopkins Updated Mar. 31, 2022 3:12 pm ET Talhe Wall Street Journal The Food and Drug Administration authorized the first antiviral pills to treat Covid-19 from Pfizer Inc. and Merck & Co. and partner Ridgeback Biotherapeutics LP in December. The authorizations came after each drugmaker’s […]
Authors: David Axe Published Apr. 03, 2022 10:47PM ET After spreading across Asia and Europe, the BA.2 subvariant of the novel coronavirus is now dominant in the United States, according to the U.S. Centers for Disease Control and Prevention. Right now, U.S. COVID cases are at a six-month low. But what happens next in the U.S. and nearby countries is hard to predict. Looking to Europe […]
Authors: Ibolya Rutkai, Meredith G. Mayer, Linh M. Hellmers, Bo Ning, Zhen Huang, Christopher J. Monjure, Carol Coyne, Rachel Silvestri, Nadia Golden, Krystle Hensley, Kristin Chandler, Gabrielle Lehmicke, Gregory J. Bix, Nicholas J. Maness, Kasi Russell-Lodrigue, Tony Y. Hu, Chad J. Roy, Robert V. Blair, Rudolf Bohm, Lara A. Doyle-Meyers, Jay Rappaport & Tracy Fischer Nature Communications volume 13, Article number: 1745 (2022) Published: 01 April 2022 Abstract Neurological manifestations are a significant complication of coronavirus disease (COVID-19), but underlying mechanisms aren’t well […]
Authors: Chris Melore Study Finds APRIL 1, 2022 COVID-19 started as a serious threat to the lungs, but it’s become just as synonymous with brain issues throughout the pandemic. Now, a new study is revealing exactly how the virus damages the central nervous system. Researchers at Tulane University say even a mild COVID infection can […]
Two new studies propose the first model for diagnosing, indexing and monitoring Post-Acute Sequelae of COVID-19 (PASC), also known as long COVID or long haul COVID. The findings also provide a framework for understanding the cause of, and potential treatment for, long COVID. Long COVID is believed to affect as many as 30 percent of […]
Authors: Hem Raj Sapkota1 and Arvind Nune2 Clin Rheumatol. 2022; 41(2): 337–348.Published online 2021 Nov 30. doi: 10.1007/s10067-021-06001-1PMCID: PMC8629735PMID: 34845562 Abstract Long-term sequel of acute COVID-19, commonly referred to as long COVID, has affected millions of patients worldwide. Long COVID patients display persistent or relapsing and remitting symptoms that include fatigue, breathlessness, cough, myalgia, arthralgia, sleep disturbance, cognitive impairment and skin rashes. […]
Authors: Amar D. Desai,*Michael Lavelle,*Brian C. Boursiquot, and Elaine Y. Wan Am J Physiol Cell Physiol. 2022 Jan 1; 322(1): C1–C11.Published online 2021 Nov 24. doi: 10.1152/ajpcell.00375.2021PMCID: PMC8721906PMID: 34817268 Abstract SARS-CoV-2 has rapidly spread across the globe and infected hundreds of millions of people worldwide. As our experience with this virus continues to grow, our understanding of both short-term and […]
Authors: Pooja Toshniwal PahariaMar 24 2022Reviewed by Danielle Ellis, B.Sc. In a recent study posted to the medRxiv* preprint server, researchers assessed the prevalence of organ impairment in long coronavirus disease 2019 (COVID-19) six months and a year post-COVID-19 at London and Oxford. Multi-organ impairment associated with long COVID-19 is a significant health burden. Standardized multi-organ evaluation […]
Authors: Madison Muller 02:30 PM IST, 30 Mar 2022 06:48 PM IST, 30 Mar 2022 Read more at: https://www.bloombergquint.com/onweb/never-had-covid-you-may-hold-key-to-beating-the-virusCopyright © Bloomberg More than half of Americans may have never had Covid, according to U.S. government data, leaving scientists wondering whether those who’ve avoided the novel coronavirus might actually be immune to the virus altogether. This […]
Authors: A. Kasielska-Trojan, J. T. Manning, M. Jabłkowski, J. Białkowska-Warzecha, A. L. Hirschberg & B. Antoszewski Scientific Reports volume 12, Article number: 4573 (2022) Cite this article Article Open Access Published: 17 March 2022 Abstract COVID-19 presents with mild symptoms in the majority of patients but in a minority it progresses to acute illness and hospitalization. Here we consider whether markers for prenatal sex hormones and postnatal stressors […]